BridgeMD
New treatment option for Malignant Brain Neoplasm
Official title Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
ClinicalTrials.gov ID: NCT06788886
What this study is testing
- What it's testing
- This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (along with their caregivers). The relationship between respiration, cardiovascular effects in the brain, mental health, and neurophysiological mechanisms are significant for patient populations facing complex health challenges, such as those with cancer and neurodegenerative disease, and their caregivers.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- STUDY 1: Participants must be physically fit enough to perform light exercise.
- STUDY 1: Should read and understand English well enough to consent, complete measures, and follow instructions.
- STUDY 1: Must have access to a smartphone or tablet.
- STUDY 2: Participants must be physically fit enough to perform light exercise.
- STUDY 2: Cancer patients may have prostate cancer, neuroendocrine tumor, or brain cancer in any stage.
You likely can't join if
- STUDY 1: Participants incompatible with MRI machines due to factors such as pacemakers or metallic implants.
- STUDY 1: Additionally, those with chronic medical conditions, including heart disease (coronary artery disease, congestive heart failure...
- STUDY 1: Participants with psychiatric conditions such as psychosis, suicidality, bipolar disorder, major depression, and substance use disorders are...
- STUDY 1: Participants serving as caregivers for any of the aforementioned conditions and for other illnesses such as cancer or neurological...
- STUDY 1: Further exclusions apply to those with severe vision, hearing impairments, have a body mass index (BMI) over 30, and those who are pregnant.
- STUDY 1: Those planning to become pregnant during the study period will be excluded.
See the full eligibility criteria
- STUDY 1: Participants must be physically fit enough to perform light exercise.
- STUDY 1: Should read and understand English well enough to consent, complete measures, and follow instructions.
- STUDY 1: Must have access to a smartphone or tablet.
- STUDY 2: Participants must be physically fit enough to perform light exercise.
- STUDY 2: Cancer patients may have prostate cancer, neuroendocrine tumor, or brain cancer in any stage.
- STUDY 2: The main focus is on pairs of cancer patients and their respective caregivers, but individual cancer patients or individual caregivers are also acceptable.
- STUDY 2: Participants should read and understand English well enough to consent, complete measures, and follow instructions.
- STUDY 2: They also must have access to a smartphone or tablet.
- STUDY 3: Participants must be physically fit enough to perform light exercise.
- STUDY 3: The patient should have multiple sclerosis.
- STUDY 3: Participants should read and understand English well enough to consent, complete measures, and follow instructions.
- STUDY 3: They also must have access to a smartphone or tablet.
- STUDY 1: Participants incompatible with MRI machines due to factors such as pacemakers or metallic implants.
- STUDY 1: Additionally, those with chronic medical conditions, including heart disease (coronary artery disease, congestive heart failure, hypertension, cardiac arrhythmia), chronic obstructive pulmonary disease (COPD)...
- STUDY 1: Participants with psychiatric conditions such as psychosis, suicidality, bipolar disorder, major depression, and substance use disorders are excluded.
- STUDY 1: Participants serving as caregivers for any of the aforementioned conditions and for other illnesses such as cancer or neurological disorders, are also excluded.
- STUDY 1: Further exclusions apply to those with severe vision, hearing impairments, have a body mass index (BMI) over 30, and those who are pregnant.
- STUDY 1: Those planning to become pregnant during the study period will be excluded.
- STUDY 2: Participants incompatible with MRI machines due to factors such as pacemakers or metallic implants are excluded, as are those with chronic lung disease (chronic obstructive pulmonary disease [COPD], cystic...
- STUDY 2: Those planning to become pregnant during the study period will be excluded.
- STUDY 3: Participants incompatible with MRI machines due to factors such as pacemakers or metallic implants are excluded, as are those with chronic lung disease (chronic obstructive pulmonary disease [COPD], cystic...
- STUDY 3: Those planning to become pregnant during the study period will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.